United States · Markets & Finance · MarketWatch

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Published by MarketWatch · United States 12 h ago

Alvotech shares rose after the company said the Food and Drug Administration has approved a supplement to the biologics license application for AVT02 adalimumab-ryvk, marketed in…

Read the full article on MarketWatch Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)

Also worth reading

Seeking Alpha

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

Fortune

Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird and dozens more cars to pay back fraud victims

Quartz

These are the longest rivers on every continent

OilPrice.com

Singapore Eyes Nuclear Power as Iran War Exposes Its Import Problem

Cointelegraph

FinCEN withdraws proposed crypto mixing rule over ‘legitimate activity’ concerns

TechCrunch